Page last updated: 2024-10-29

ketanserin and Syndrome

ketanserin has been researched along with Syndrome in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hughes, EW1
Hodkinson, BP1
Koshikawa, N1
Smokcum, RW1
Stephenson, JD1

Other Studies

2 other studies available for ketanserin and Syndrome

ArticleYear
Carcinoid syndrome: the combined use of ketanserin and octreotide in the management of an acute crisis during anaesthesia.
    Anaesthesia and intensive care, 1989, Volume: 17, Issue:3

    Topics: Anesthesia; Breast Neoplasms; Carcinoid Tumor; Female; Humans; Hypertension; Intraoperative Complica

1989
Is waning of a 5-hydroxytryptamine (5-HT)-mediated syndrome due to 5-HT2 receptor down-regulation?
    Neuroscience letters, 1985, Apr-19, Volume: 55, Issue:3

    Topics: Animals; Cerebral Cortex; Ketanserin; Male; Myoclonus; Paroxetine; Phenelzine; Piperidines; Rats; Ra

1985